europa press | fotos

Empresas.- Sandoz completa con éxito la escisión de Novartis y persigue el liderazgo de genéricos y biosimilares

FILED - 11 January 2016, Thuringia, Rudolstadt: A view of the company grounds of the pharmaceutical company Sandoz Aeropharm in Rudolstadt. Sandoz, a unit of Swiss biopharmaceutical major Novartis, said on Monday that it has completed acquiring the worldwide brand rights of the antifungal agent Mycamine from Astellas Pharma, a Japanese pharmaceutical company. Photo: Sebastian Kahnert/dpa-Zentralbild/dpa
Código:
5482938
Fecha:
11/01/2016
Dimensiones:
4696 x 3126 (1.05MB)
Lugar:
Rudolstadt - Germany
Fotos del Tema:
1
Pie de Foto:

FILED - 11 January 2016, Thuringia, Rudolstadt: A view of the company grounds of the pharmaceutical company Sandoz Aeropharm in Rudolstadt. Sandoz, a unit of Swiss biopharmaceutical major Novartis, said on Monday that it has completed acquiring the worldwide brand rights of the antifungal agent Mycamine from Astellas Pharma, a Japanese pharmaceutical company. Photo: Sebastian Kahnert/dpa-Zentralbild/dpa
Fecha:
leer más 11/01/2016. leer menos

Foto de archivo

Firma: Sebastian Kahnert / Dpa-Zentralbil - Only For Use In Spain
Para descargar esta foto, entre como abonado o contáctenos:
Teléfono+34 91 359 26 00 - Emailarchivo@europapress.es